Quirk, R. A., Davies, M. C., Tendler, S. J. B., Chan, W. C., and Shakesheff, K. M. Controlling biological interactions with poly(lactic acid) by surface entrapment modification. Langmuir 2001, 17, 2817-2820.
|
|
Quirk, R. A., Chan, W. C., Davies, M. C., Tendler, S. J., and Shakesheff,
K. M. Poly(L-lysine)-GRGDS as a biomimetic surface modifier for poly(lactic
acid). Biomaterials 2001, 22, 865-872. [PUBMED] |
|
Quirk, R. A., Briggs, D., Davies, M. C., Tendler, S. J. B., and Shakesheff, K. M. Characterization of the spatial distributions of entrapped polymers following the surface engineering of poly(lactic acid). Surf. Interface Anal. 2001, 31, 46-50.
|
|
Howdle, S. M., Watson, M. S., Whitaker, M. J., Popov, V. K., Davies, M. C., Mandel, F. S., Wang, J. D., and Shakesheff, K. M. Supercritical fluid mixing: preparation of thermally sensitive polymer composites containing bioactive materials. Chem. Commun. 2001, 109-110.
|
|
Whitaker, M. J., Quirk, R. A., Howdle, S. M., and Shakesheff, K.
M. Growth factor release from tissue engineering scaffolds. J.
Pharm. Pharmacol. 2001, 53, 1427-1437. [PUBMED] |
|
Salem, A. K., Cannizzaro, S. M., Davies, M. C., Tendler, S. J.,
Roberts, C. J., Williams, P. M., and Shakesheff, K. M. Synthesis and
characterisation of a degradable poly(lactic acid)-poly(ethylene glycol)
copolymer with biotinylated end groups. Biomacromolecules
2001, 2, 575-580. [PUBMED] |
|
Yang, X. B., Roach, H. I., Clarke, N. M., Howdle, S. M., Quirk,
R., Shakesheff, K. M., and Oreffo, R. O. Human osteoprogenitor growth
and differentiation on synthetic biodegradable structures after surface
modification. Bone 2001, 29, 523-531. [PUBMED] |
|
Dexter, S. J., Pearson, R. G., Davies, M. C., Camara, M., and Shakesheff,
K. M. A comparison of the adhesion of mammalian cells and Staphylococcus
epidermidis on fibronectin-modified polymer surfaces. J. Biomed.
Mater. Res. 2001, 56, 222-227. [PUBMED] |
|
Shakesheff, K.M. Stop Or Grow. Chem. Br. 2001
37, 29-30. [PUBMED] |
|
Rose, F.R.A.J., Shakesheff, K.M., Quirk, R.A. Tissue Engineering - New Technologies at the Interface between Pharmaceutical and Cell Sciences. Business Briefing: Pharmatech 2001, 189-192.
|
|
Bhandari, R. N., Riccalton, L. A., Lewis, A. L., Fry, J. R., Hammond,
A. H., Tendler, S. J., and Shakesheff, K. M. Liver tissue engineering:
a role for co-culture systems in modifying hepatocyte function and
viability. Tissue Eng. 2001, 7, 345-357.
[PUBMED] |
|
Riccalton-Banks, L. A., Bhandari, R. N. B., Fry, J. R., and Shakesheff, K. M. Maintaining in vitro functionality of hepatocyte cultures. Toxicology 2001, 168, 122-122.
|
|